Synthesis and biological evaluation of truncated α-tubulin-binding pironetin analogues lacking alkyl pendants in the side chain or the dihydropyrone ring

被引:19
作者
Panos, Julian [1 ]
Diaz-Oltra, Santiago [1 ]
Sanchez-Peris, Maria [1 ]
Garcia-Pla, Jorge [1 ]
Murga, Juan [1 ]
Falomir, Eva [1 ]
Carda, Miguel [1 ]
Redondo-Horcajo, Mariano [2 ]
Fernando Diaz, J. [2 ]
Barasoain, Isabel [2 ]
Alberto Marco, J. [3 ]
机构
[1] Univ Jaume 1, Depart Q Inorgan & Organ, E-12071 Castellon de La Plana, Spain
[2] CSIC, Ctr Invest Biol, Madrid 28040, Spain
[3] Univ Valencia, Depart Q Organ, E-46100 Valencia, Spain
关键词
ENANTIOSELECTIVE TOTAL-SYNTHESIS; ASYMMETRIC ALDOL ADDITIONS; MICROTUBULE-ACTIVE AGENTS; N-ACYL OXAZOLIDINONES; CELL-CYCLE ARREST; EFFICIENT SYNTHESIS; CONFORMATION DESIGN; STABILIZING AGENTS; NATURAL-PRODUCTS; (-)-PIRONETIN;
D O I
10.1039/c3ob40854j
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The preparation of several new truncated analogues of the natural dihydropyrone pironetin is described. They differ from the natural product mainly in the suppression of some of the alkyl pendants in either the side chain or the dihydropyrone ring. Their cytotoxic activity and their interactions with tubulin have been investigated. It has been found that all analogues are cytotoxic towards two either sensitive or resistant tumoral cell lines with similar IC50 values in each case, thus strongly suggesting that, like natural pironetin, they also display a covalent mechanism of action. Their cytotoxicity is, however, lower than that of the parent compound. This indicates that all alkyl pendants are necessary for the full biological activity, with the ethyl group at C-4 seemingly being particularly relevant. Most likely, the alkyl groups cause a restriction in the conformational mobility of the molecule and reduce the number of available conformations. This makes it more probable that the molecule preferentially adopts a shape which fits better into the binding point in alpha-tubulin.
引用
收藏
页码:5809 / 5826
页数:18
相关论文
共 96 条
[1]   Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action [J].
Abal, M. ;
Andreu, J. M. ;
Barasoain, I. .
CURRENT CANCER DRUG TARGETS, 2003, 3 (03) :193-203
[2]   Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules [J].
Alberto Marco, J. ;
Garcia-Pla, Jorge ;
Carda, Miguel ;
Murga, Juan ;
Falomir, Eva ;
Trigili, Chiara ;
Notararigo, Sara ;
Fernando Diaz, J. ;
Barasoain, Isabel .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (05) :1630-1637
[3]   Anticancer drugs from nature - natural products as a unique source of new microtubule-stabilizing agents [J].
Altmann, Karl-Heinz ;
Gertsch, Juerg .
NATURAL PRODUCT REPORTS, 2007, 24 (02) :327-357
[4]   Microtubule structure and its stabilisation [J].
Amos, LA .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (15) :2153-2160
[5]  
Anderson HJ, 1997, CANCER CHEMOTH PHARM, V39, P223
[6]  
[Anonymous], CURRENT CHEM BIOL
[7]   The metathesis reactions: from a historical perspective to recent developments [J].
Astruc, D .
NEW JOURNAL OF CHEMISTRY, 2005, 29 (01) :42-56
[8]   On the influence of chiral auxiliaries in the stereoselective cross-coupling reactions of titanium enolates and acetals [J].
Baiget, Jessica ;
Cosp, Annabel ;
Galvez, Erik ;
Gomez-Pinal, Loreto ;
Romea, Pedro ;
Urpi, Felix .
TETRAHEDRON, 2008, 64 (24) :5637-5644
[9]   Natural, semisynthetic and synthetic microtubule inhibitors for cancer therapy [J].
Beckers, T ;
Mahboobi, S .
DRUGS OF THE FUTURE, 2003, 28 (08) :767-785
[10]   Molecular Modeling Approaches to Study the Binding Mode on Tubulin of Microtubule Destabilizing and Stabilizing Agents [J].
Botta, Maurizio ;
Forli, Stefano ;
Magnani, Matteo ;
Manetti, Fabrizio .
TUBULIN-BINDING AGENTS: SYNTHETIC, STRUCTURAL AND MECHANISTIC INSIGHTS, 2009, 286 :279-328